These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 2555723)

  • 1. Pharmacological properties of voltage-dependent calcium channels in functional microvessels isolated from rat brain.
    Morel N; Godfraind T
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):442-51. PubMed ID: 2555723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective modulation by membrane potential of the interaction of some calcium entry blockers with calcium channels in rat mesenteric artery.
    Morel N; Godfraind T
    Br J Pharmacol; 1988 Sep; 95(1):252-8. PubMed ID: 2851351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioligand and functional estimates of the interaction of the 1,4-dihydropyridines, isradipine and lacidipine, with calcium channels in smooth muscle.
    Salomone S; Godfraind T
    Br J Pharmacol; 1993 May; 109(1):100-6. PubMed ID: 8495233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged depolarization increases the pharmacological effect of dihydropyridines and their binding affinity for calcium channels of vascular smooth muscle.
    Morel N; Godfraind T
    J Pharmacol Exp Ther; 1987 Nov; 243(2):711-5. PubMed ID: 2824756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (+)-[3H]-PN 200-110 binding to cell membranes and intact strips of portal vein smooth muscle: characterization and modulation by membrane potential and divalent cations.
    Dacquet C; Loirand G; Rakotoarisoa L; Mironneau C; Mironneau J
    Br J Pharmacol; 1989 May; 97(1):256-62. PubMed ID: 2524235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization in rat aorta of the binding sites responsible for blockade of noradrenaline-evoked calcium entry by nisoldipine.
    Morel N; Godfraind T
    Br J Pharmacol; 1991 Feb; 102(2):467-77. PubMed ID: 1826619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
    Wei XY; Rutledge A; Triggle DJ
    Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular approach to the calcium channel.
    Glossmann H; Ferry DR; Goll A; Linn T
    Adv Myocardiol; 1985; 5():41-76. PubMed ID: 2578683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of the dihydropyridine calcium channel blocker (+)-[3H] isopropyl-4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-methoxycarbonyl-2, 6-dimethyl-3-pyridinecarboxylate (PN200-110) to RINm5F membranes and cells: characterization and functional significance.
    Yaney GC; Stafford GA; Henstenberg JD; Sharp GW; Weiland GA
    J Pharmacol Exp Ther; 1991 Aug; 258(2):652-62. PubMed ID: 1713965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding sites for 1,4-dihydropyridine Ca(2+)-channel modulators in rat intestinal smooth muscle.
    Salomone S; Wibo M; Morel N; Godfraind T
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Dec; 344(6):698-705. PubMed ID: 1837846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrovascular effect of calcium antagonists.
    Morel N; Godfraind T
    Eur Neurol; 1990; 30 Suppl 2():10-5; discussion 39-41. PubMed ID: 2318232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of dihydrothienopyridine S312 enantiomers on L-type Ca2+ channels in isolated rat aorta and cerebral microvessels.
    Dessy C; Salomone S; Morel N; Godfraind T
    Eur J Pharmacol; 1993 Feb; 231(3):435-42. PubMed ID: 8449235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dihydropyridines on calcium channels in isolated smooth muscle cells from rat vena cava.
    Mironneau J; Yamamoto T; Sayet I; Arnaudeau S; Rakotoarisoa L; Mironneau C
    Br J Pharmacol; 1992 Feb; 105(2):321-8. PubMed ID: 1373097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110.
    Ferry DR; Goll A; Glossmann H
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):276-7. PubMed ID: 6312337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of calcium entry blockers on calcium-dependent contractions of rat portal vein.
    Dacquet C; Mironneau C; Mironneau J
    Br J Pharmacol; 1987 Sep; 92(1):203-11. PubMed ID: 2959345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the dihydropyridine binding sites of rat neocortical synaptosomes and microvessels.
    Dooley DJ; Mählmann H; Brenner O; Osswald H
    J Neurochem; 1987 Sep; 49(3):900-4. PubMed ID: 3039058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of Ca2+ channels in smooth muscle.
    Mironneau J
    Z Kardiol; 1991; 80 Suppl 7():43-6. PubMed ID: 1665262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of pinaverium (a quaternary ammonium compound) with 1,4-dihydropyridine binding sites in rat ileum smooth muscle.
    Feron O; Wibo M; Christen MO; Godfraind T
    Br J Pharmacol; 1992 Feb; 105(2):480-4. PubMed ID: 1313732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High affinity specific [3H](+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart.
    Lee HR; Roeske WR; Yamamura HI
    Life Sci; 1984 Aug; 35(7):721-32. PubMed ID: 6088927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of [3H]dihydropyridine binding by activation of protein kinase C in vascular smooth muscle.
    Mironneau C; Rakotoarisoa L; Sayet I; Mironneau J
    Eur J Pharmacol; 1991 Nov; 208(3):223-30. PubMed ID: 1663046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.